CD274 and neoplasm: Treatment with Sigma1 can induce autophagy in co-cultured T-cells and tumor cells, leading to degradation of PD-L1 and suppression of PD-1 and PD-L1 interaction, which could favor immunotherapy effects due to immune microenvironment modulation (201).